U.S. STOCKS ON THE MOVE-MercadoLibre, DoorDash, Coinbase
Brief: Exicure Inc Says Received Nasdaq Delinquency Notice On Late Filing Of Its Form 10-K
Brief: Exicure And Bluejay Therapeutics Enter Into A Patent License Agreement To Develop Cavrotolimod For The Treatment Of Hepatitis
Brief: Exicure Says Co Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Brief: Exicure will correct some expenses from R&D for quarter ended Sept 30
Brief: Exicure, Inc. Received Nasdaq Delinquency Notice On Late Filing Of Its Form 10-Q
Brief: Exicure Inc - On October 3, 2023, Northwestern Notified Company That It Was Terminating 2014 License
Brief: Exicure Received Letter From Nasdaq That Co Has Not Been Compliance With The Minimum Bid Price Requirement
Brief: Exicure Inc Names Paul Kang As CEO
Brief: Exicure Notified Nasdaq That Co Continued To Be Not In Compliance With Listing Rule
Brief: Exicure Seeks To Raise Capital In Q3 To Fund Operations Through 2024
Brief: CBI Usa, Inc Expects To Continue To Explore, Pursue Additional Board Representation In Exicure Inc & Any Additional Actions They Consider Necessary
Brief: Exicure Announces Support Of CEO In Exploring Strategic Alternatives
Brief: Exicure, Inc. Received Nasdaq Delinquency Notice On Late Filing Of Its Form 10-Q
Brief: Exicure Inc Says On May 10, Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Brief: Exicure Inc Announces Investment In Korean SNS Platform Cyworld
Brief: Exicure Inc Announces Appointment Of New CEO And CFO And Changes To Board Of Directors
Brief: Exicure Reports Full Year 2022 Financial Results
Brief: Exicure Inc Says On Feb 21, Received Notice From Nasdaq Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard Transfer Of Listing